Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

IMX INSULIN

K-Number: K920109 · 1992-05-07

Decision Date1992-05-07
Product CodeCFP
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

IMX INSULIN is the device name listed in this FDA 510(k) record. The listed applicant is Abbott Laboratories. It received FDA 510(k) clearance on 1992-05-07 under 510(k) number K920109. The device is classified under product code CFP. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the IMX INSULIN?

IMX INSULIN is a medical device that received FDA 510(k) clearance on 1992-05-07. The listed applicant is Abbott Laboratories. The 510(k) number is K920109.

When did IMX INSULIN receive FDA 510(k) clearance?

IMX INSULIN received FDA 510(k) clearance on 1992-05-07, under 510(k) number K920109.

Who is the listed applicant for IMX INSULIN?

The FDA 510(k) record lists Abbott Laboratories as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for IMX INSULIN?

The FDA product code for IMX INSULIN is CFP.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Abbott Laboratories as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 876 devices →

Related Devices (Code: CFP)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑